Key result
Metabolic syndrome elevates chronic kidney disease risk, highlighting key targets for therapeutic intervention.
Answers are grounded in this paper and cite their sources.
Metabolic syndrome is characterized by a clustering of cardiovascular risk factors, including abdominal obesity, elevated blood pressure and glucose concentrations, and dyslipidemia. The presence of this clinical entity is becoming more pervasive throughout the globe as the prevalence of obesity increases worldwide. Moreover, there is increased recognition of the complications and mortality related to this syndrome. This paper looks to examine the link between metabolic syndrome and the development of chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
LaGuardia et al. (2012) conducted a review in Metabolic syndrome and chronic kidney disease. Metabolic syndrome was evaluated on Development of chronic kidney disease. Metabolic syndrome and its pathophysiology and intervention strategies are reviewed in relation to the risk of developing chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: